跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
HALOETTE - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
HALOETTE
Authorized
STANDARD
HALOETTE
searchlight pharma inc
🇨🇦 Health Canada
Approval Date
Jul 4, 2025
Approval ID
e93c0531438ab471
Company
searchlight pharma inc
Type
Standard
Approval Details
Approval Id
e93c0531438ab471
Drug Approval Canada Name
HALOETTE
Product Name
HALOETTE
Status
Marketed
Status Date
2021-09-29
Original Market Date
2021-09-29
Din
02520028
Drug Class
Human
Dosage Form
Ring (Slow-Release)
Route Of Administration
Vaginal
Schedule
Prescription
Ahfs
68:12.00
Atc Original
G02BB01 VAGINAL RING WITH PROGESTOGEN AND ESTROGEN
Atc Name
g 02 bb 01
Aig Number
0250087001
Company Name
searchlight pharma inc
Company Address
1600 Rue Notre Dame Ouest, Suite 312, Montreal, Quebec, Canada, H3J 1M1
Active Ingredients
ETONOGESTREL
11.7 MG
ETHINYL ESTRADIOL
2.7 MG
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Jul 4, 2025
Approval ID
e93c0531438ab471
Type
Standard
Back to Health Canada Approvals